TY - JOUR
T1 - Biophysical properties and functional consequences of reactive oxygen species (ROS)-induced ROS release in intact myocardium
AU - Biary, Nora
AU - Xie, Chaoqin
AU - Kauffman, Justin
AU - Akar, Fadi G.
PY - 2011/11
Y1 - 2011/11
N2 - Reactive oxygen species (ROS)-induced ROS release (RIRR) is a fundamental mechanism by which cardiac mitochondria respond to elevated ROS levels by stimulating endogenous ROS production in a regenerative, autocatalytic process that ultimately results in global oxidative stress (OS), cellular dysfunction and death. Despite elegant studies describing the phenomenon of RIRR under artificial conditions such as photo-induced oxidation of discrete regions within cardiomyocytes, the existence, biophysical properties and functional consequences of RIRR in intact myocardium remain unclear. Here, we used a semi-quantitative approach of optical superoxide (O 2 -) mapping using dihydroethidium (DHE) fluorescence to explore RIRR, its arrhythmic consequences and underlying mechanisms in intact myocardium. Initially, perfusion of rat hearts with 200 μm H 2O 2 for 40 min (n= 4) elicited two distinct O 2 - peaks that were readily distinguished by their timing and amplitude. The first peak (P1), which was generated rapidly (within 5-8 min of H 2O 2 perfusion) was associated with a relatively limited (10 ± 2%) rise in normalized O 2 - levels relative to baseline. In contrast, the second peak (P2) occurred 19-26 min following onset of H 2O 2 perfusion and was associated with a significantly greater amplitude compared to P1. Spatio-temporal ROS mapping during P2 revealed active O 2 - propagation across the myocardium at a velocity of ∼20 μm s -1. Exposure of hearts (n= 18) to a short (10 min) episode of H 2O 2 perfusion revealed consistent generation of P2 by high (≥200 μm, 8/8) but not lower (≤100 μm, 3/8) H 2O 2 concentrations (P < 0.03). In these hearts, onset of P2 occurred following, not during, the 10 min OS protocol, consistent with RIRR. Importantly, P2 (+) hearts exhibited a markedly greater (by 3.8-fold, P < 0.001) arrhythmia score compared to P2 (-) hearts. To explore the mechanism underlying RIRR in intact myocardium, hearts were perfused with either cyclosporin A (CsA) or 4'-chlorodiazepam (4'-Cl-DZP) to inhibit the mitochondrial permeability transition pore (mPTP) or the inner membrane anion channel (IMAC), respectively. Surprisingly, perfusion with CsA failed to suppress (P= 0.75, n.s.) or even delay H 2O 2-induced P2 or the incidence of arrhythmias compared to untreated hearts. In sharp contrast, perfusion with 4'-Cl-DZP markedly blunted O 2 - levels during P2, and suppressed the incidence of sustained ventricular tachycardia or ventricular fibrillation (VT/VF). Finally, perfusion of hearts with the synthetic superoxide dismutase/catalase mimetic EUK-134 completely abolished the H 2O 2-mediated RIRR response as well as the incidence of arrhythmias. These findings extend the concept of RIRR to the level of the intact heart, establish regenerative O 2 - production as the mediator of RIRR-related arrhythmias and reveal their strong dependence on IMAC and not the mPTP in this acute model of OS.
AB - Reactive oxygen species (ROS)-induced ROS release (RIRR) is a fundamental mechanism by which cardiac mitochondria respond to elevated ROS levels by stimulating endogenous ROS production in a regenerative, autocatalytic process that ultimately results in global oxidative stress (OS), cellular dysfunction and death. Despite elegant studies describing the phenomenon of RIRR under artificial conditions such as photo-induced oxidation of discrete regions within cardiomyocytes, the existence, biophysical properties and functional consequences of RIRR in intact myocardium remain unclear. Here, we used a semi-quantitative approach of optical superoxide (O 2 -) mapping using dihydroethidium (DHE) fluorescence to explore RIRR, its arrhythmic consequences and underlying mechanisms in intact myocardium. Initially, perfusion of rat hearts with 200 μm H 2O 2 for 40 min (n= 4) elicited two distinct O 2 - peaks that were readily distinguished by their timing and amplitude. The first peak (P1), which was generated rapidly (within 5-8 min of H 2O 2 perfusion) was associated with a relatively limited (10 ± 2%) rise in normalized O 2 - levels relative to baseline. In contrast, the second peak (P2) occurred 19-26 min following onset of H 2O 2 perfusion and was associated with a significantly greater amplitude compared to P1. Spatio-temporal ROS mapping during P2 revealed active O 2 - propagation across the myocardium at a velocity of ∼20 μm s -1. Exposure of hearts (n= 18) to a short (10 min) episode of H 2O 2 perfusion revealed consistent generation of P2 by high (≥200 μm, 8/8) but not lower (≤100 μm, 3/8) H 2O 2 concentrations (P < 0.03). In these hearts, onset of P2 occurred following, not during, the 10 min OS protocol, consistent with RIRR. Importantly, P2 (+) hearts exhibited a markedly greater (by 3.8-fold, P < 0.001) arrhythmia score compared to P2 (-) hearts. To explore the mechanism underlying RIRR in intact myocardium, hearts were perfused with either cyclosporin A (CsA) or 4'-chlorodiazepam (4'-Cl-DZP) to inhibit the mitochondrial permeability transition pore (mPTP) or the inner membrane anion channel (IMAC), respectively. Surprisingly, perfusion with CsA failed to suppress (P= 0.75, n.s.) or even delay H 2O 2-induced P2 or the incidence of arrhythmias compared to untreated hearts. In sharp contrast, perfusion with 4'-Cl-DZP markedly blunted O 2 - levels during P2, and suppressed the incidence of sustained ventricular tachycardia or ventricular fibrillation (VT/VF). Finally, perfusion of hearts with the synthetic superoxide dismutase/catalase mimetic EUK-134 completely abolished the H 2O 2-mediated RIRR response as well as the incidence of arrhythmias. These findings extend the concept of RIRR to the level of the intact heart, establish regenerative O 2 - production as the mediator of RIRR-related arrhythmias and reveal their strong dependence on IMAC and not the mPTP in this acute model of OS.
UR - http://www.scopus.com/inward/record.url?scp=80055004420&partnerID=8YFLogxK
U2 - 10.1113/jphysiol.2011.214239
DO - 10.1113/jphysiol.2011.214239
M3 - Article
C2 - 21825030
AN - SCOPUS:80055004420
SN - 0022-3751
VL - 589
SP - 5167
EP - 5179
JO - Journal of Physiology
JF - Journal of Physiology
IS - 21
ER -